Elsevier Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Hsu
    Hsu
  3. Kris
    Kris
  4. Berger
    Berger
  5. Giralt
    Giralt
  6. Perales
    Perales
  7. Riely
    Riely
  8. Hanash
    Hanash
  9. Peled
    Peled
  10. Solit
    Solit

Groups

  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)
  7. Center for Hematologic Malignancies (166)
  8. Hematologic Malignancies, Division of (151)
  9. Sloan Kettering Institute Postdocs (125)
  10. Bone Marrow Transplant (116)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (182)
  3. Review (14)
  4. Book Section (9)
  5. Editorial (8)
  6. Conference Paper (1)
  7. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)

More Groups

People
  1. Marc Ladanyi (97)
  2. Marcel Van Den Brink (61)
  3. Katharine Hsu (52)
  4. Mark Kris (44)
  5. Michael Berger (38)
  6. Miguel-Angel Perales (37)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (26)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (100)
  2. Journal of Thoracic Oncology (89)
  3. Urologic Oncology: Seminars and Original Investigations (31)
  4. European Journal of Cancer (30)
  5. International Journal of Radiation Oncology, Biology, Physics (18)
  6. Transplantation and Cellular Therapy (13)

More Publications

Results (420)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetically engineered donor T cells for BMT immunotherapy: Expression of trail and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations
    Journal Article

    Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Frequency of EGFR and KRAS mutations in lung adenocarcinomas in african americans
    Journal Article

    Reinersman, J. M.; Johnson, M. L.; Riely, G. J.; Chitale, D. A.; Nicastri, A. D.; Soff, G. A.; Schwartz, A. G.; Sima, C. S.; Ayalew, G.; Lau, C.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Over-expression of trail on donor T cells simultaneously ameliorates GVHD and enhances GVT
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Kappel, L. W.; Dogan, Y.; Yim, N.; Rao, U.; Smith, O. M.; Jenq, R. R.; Zakrzewski, J.; Na, I. K.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • T-cell depleted allografts from unrelated donors confer a low risk of relapse on patients with hematologic malignancies
    Meeting Abstract

    Jakubowski, A. A.; Small, T.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H. R.; Hsu, K. C.; Kernan, N.; Koehne, G.; Perales, M. A.; Prockop, S.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Temporary licensing of hyporesponsive NK cells following allogeneic HCT is not affected by T-cells in the stem cell allograft
    Meeting Abstract

    Tarek, N.; Yu, J.; Venstrom, J. M.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • The Memorial Sloan-Kettering experience with allogeneic stem cell transplantation for T cell non-Hodgkins lymphomas
    Meeting Abstract

    Goldberg, J. D.; Chou, J.; Jakubowski, A. A.; Arcila, M. E.; Teruya-Feldstein, J.; Horwitz, S.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H. R.; Hsu, K.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Relapse after allogeneic hematopoietic cell therapy
    Journal Article

    Van Den Brink, M. R.; Porter, D. L.; Giralt, S.; Lu, S. X.; Jenq, R. R.; Hanash, A.; Bishop, M. R.
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): A clinicopathologic and molecular study
    Journal Article

    Rivera, M.; Ricarte-Filho, J.; Patel, S.; Tuttle, M.; Shaha, A.; Shah, J. P.; Fagin, J. A.; Ghossein, R. A.
    Human Pathology (2010)

    Fulltext@MSK | Save